New Frontiers in Biologic Drugs Discovery and Development

May 16th, 2014 | Categories: 2014 | Tags:

New Frontiers in Biologic Drugs Discovery and Development

 

Date: June 6, 2014

Time: 08:30-16:00

Venue: 張榮發基金會國際會議中心 1001會議廳 (台北市中正區中山南路11號 10F)

 

Agenda

Time

Speaker

Title

08: 30 – 09: 00

Registration

09: 00 – 09: 10

Dr. Johnsee Lee

Chairman

Development Center
for Biotechnology

Opening Remarks

09: 10 – 10: 10

Keynote Speaker

Dr. Peter Senter

VP, Chemistry

Seattle Genetics

Antibody Drug Conjugates: Putting Together a Clinically Approved Drug,
and the Challenges that Remain

10: 10 – 11: 00

Dr. Herren Wu

Vice President, R&D

Head of Antibody Discovery & Protein Engineering MedImmune

Developing Armed Antibodies for Cancer Treatment

11: 00 – 11: 20

Coffee Break

11: 20 – 12: 20

Dr. Hsieng Lu

Former Director, Department of Therapeutic Discovery

Amgen

Development of Large Molecule Clinical Leads: Engineering and Optimization of Therapeutic Proteins, Antibodies and Derivatives

12: 20 – 13: 35

Lunch

13: 35 – 14: 35

Dr. Michael Chang

Chairman

OBI PHARMA

OBI-822, a novel active immune agent for cancer

14:35 – 15:35

Roundtable Discussions

15:35 – 15:50

Dr. Thomas Yuan

Acting Vice President

Development Center for Biotechnology

Closing Remarks

15:50-16:30

Networking Reception
|

Referrer Plugin made by Electric Guitars.